Adjunctive memantine in clozapine-treated refractory schizophrenia: an open-label 1-year extension study.
about
Single-Dose Memantine Improves Cortical Oscillatory Response Dynamics in Patients with Schizophrenia.Memantine add-on to antipsychotic treatment for residual negative and cognitive symptoms of schizophrenia: a meta-analysis.Positive Modulatory Interactions of NMDA Receptor GluN1/2B Ligand Binding Domains Attenuate Antagonists Activity.Memantine add-on to clozapine treatment for residual negative symptoms of schizophrenia.Response to the letter from Dr. Veerman and colleagues.Medications Used for Cognitive Enhancement in Patients With Schizophrenia, Bipolar Disorder, Alzheimer's Disease, and Parkinson's Disease.
P2860
Adjunctive memantine in clozapine-treated refractory schizophrenia: an open-label 1-year extension study.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Adjunctive memantine in clozap ...... -label 1-year extension study.
@en
Adjunctive memantine in clozap ...... -label 1-year extension study.
@nl
type
label
Adjunctive memantine in clozap ...... -label 1-year extension study.
@en
Adjunctive memantine in clozap ...... -label 1-year extension study.
@nl
prefLabel
Adjunctive memantine in clozap ...... -label 1-year extension study.
@en
Adjunctive memantine in clozap ...... -label 1-year extension study.
@nl
P2093
P2860
P1476
Adjunctive memantine in clozap ...... -label 1-year extension study.
@en
P2093
J B Deijen
P F J Schulte
S R T Veerman
P2860
P304
P356
10.1017/S0033291716002476
P407
P577
2016-10-25T00:00:00Z